AbbVie Inc
Held by 19 tracked managers as of Q2 2026 · CUSIP ⓘCUSIP: A 9-character ID for one specific security - one share class of one company, or one bond. Tickers can change and can mean different things in different countries; a CUSIP always identifies exactly the same security, which is why filings use it. Guide 00287Y109 · Sector ⓘGICS sectors: The 11-sector system most investors know (Global Industry Classification Standard): Technology, Health Care, Financials and so on. This site assigns each company a GICS-style sector from its SIC code, with a few hand corrections, so sector pages match the names investors expect. Guide
Educational and informational only, not personalized investment advice. Based on public filings that may be delayed or contain errors; verify with the original filings. Disclaimer
Tracked capital in this stock
Total value held (area) and number of managers (line). Dips can mean a large holder filed that quarter confidentially (e.g. Norges Bank in Q1/Q3).
Aggregate buying and selling
Net share change reported each quarter
Who owns ABBV?
🔒 The 'who added and who trimmed' chart is a Plus feature
You're viewing the Free plan. Upgrade to unlock The 'who added and who trimmed' chart — every paid plan starts with a 7-day free trial, and you can cancel in two clicks.
Who owns ABBV? — Q2 2026
Holders ranked by position size, with each one's quarter-over-quarter change.
Column filters
| # | Manager | Fund | Shares | Value ↓ | % of their portfolio | QoQ | Δ shares | Δ shares % | Est. Δ value ⓘChange in shares × this quarter's price |
|---|---|---|---|---|---|---|---|---|---|
| 1 | Norges Bank | Norges Bank Investment Management | 25.55M | $6.43B | 0.6% | — | — | — | — |
| 2 | Ken Fisher | Fisher Asset Management | 9.50M | $2.39B | 0.7% | Added | +405.9K | +4.5% | +$102.14M |
| 3 | Boston Partners | Boston Partners Global Investors | 4.78M | $1.20B | 1.1% | Added | +1.4M | +39.3% | +$339.34M |
| 4 | Ken Griffin | Citadel Advisors | 3.17M | $797.64M | 0.5% | Added | +2.7M | +546.5% | +$674.27M |
| 5 | David Shaw | D.E. Shaw & Co. | 2.10M | $529.03M | 0.3% | Added | +1.4M | +212.4% | +$359.68M |
| 6 | Israel Englander | Millennium Management | 1.52M | $381.61M | 0.3% | Added | +840.7K | +124.4% | +$211.56M |
| 7 | Mawer | Mawer Investment Management | 431.25K | $108.52M | 0.7% | Added | +121.4K | +39.2% | +$30.54M |
| 8 | Steve Cohen | Point72 Asset Management | 366.84K | $92.31M | 0.1% | New | +366.8K | — | +$92.31M |
| 9 | Two Sigma | Two Sigma Investments | 198.25K | $49.89M | 0.0% | Added | +19.8K | +11.1% | +$4.99M |
| 10 | Larry Robbins | Glenview Capital | 148.91K | $37.47M | 0.7% | New | +148.9K | — | +$37.47M |
| 11 | Bridgeway | Bridgeway Capital Management | 109.54K | $27.57M | 0.5% | Reduced | -2.5K | -2.3% | -$637.40K |
| 12 | Torray | Torray Investment Partners | 82.60K | $20.79M | 2.8% | Reduced | -11.0K | -11.7% | -$2.76M |
| 13 | Fred Alger | Fred Alger Management | 67.74K | $17.05M | 0.1% | Reduced | -41.1K | -37.7% | -$10.34M |
| 14 | Mario Gabelli | GAMCO Investors | 13.60K | $3.42M | 0.0% | Reduced | -1.5K | -10.1% | -$382.74K |
| 15 | Ray Dalio | Bridgewater Associates | 11.78K | $2.96M | 0.0% | Reduced | -18.6K | -61.2% | -$4.68M |
| 16 | Dodge & Cox | Dodge & Cox | 10.39K | $2.62M | 0.0% | Held | 0 | 0.0% | $0 |
| 17 | John Ciampaglia & Eric Sprott | Sprott Inc | 7.75K | $1.95M | 0.1% | New | +7.7K | — | +$1.95M |
| 18 | Bill Nygren | Harris Associates (Oakmark Funds) | 2.42K | $608.97K | 0.0% | Reduced | -262 | -9.8% | -$65.93K |
| 19 | Jeremy Grantham | GMO | 885 | $222.70K | 0.0% | New | +885 | — | +$222.70K |
Column filters
| Manager | Fund | Shares sold | Value last quarter ↓ |
|---|---|---|---|
| Ron Baron | Baron Capital (BAMCO) | -8.0K | $1.74M |
Politician trades
Column filters
| Politician | Date | Ticker | Asset | Type | Reported range ⓘThe dollar range the politician reported. Exact amounts are not disclosed. | Est. size ⓘOur estimate only: the midpoint of the reported range. | Owner | Account ⓘSubholding Of: the account the trade was in, as named on the report (e.g. an IRA or a brokerage account). The same stock bought on the same day in different accounts is a separate trade in each account. | Filed ↓ | Filing delay ⓘDays between the trade and the report. Over 45 days is late under the STOCK Act. | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Julia Letlow Politician | Oct 23, 2024 | ABBV | AbbVie Inc. Common Stock (ABBV) [ST] | Purchase | $1,001 - $15,000 | Est. $8,000 (midpoint of reported range $1,001–$15,000) | Self | Merrill Lynch Investment Account #025 | Jan 13, 2026 | 447 days Late | PTR ↗ |
| Julia Letlow Politician | Jan 24, 2025 | ABBV | AbbVie Inc. Common Stock (ABBV) [ST] | Sale | $1,001 - $15,000 | Est. $8,000 (midpoint of reported range $1,001–$15,000) | Self | Merrill Lynch Investment Account #025 | Jan 13, 2026 | 354 days Late | PTR ↗ |
| Julia Letlow Politician | Apr 28, 2025 | ABBV | AbbVie Inc. Common Stock (ABBV) [ST] | Purchase | $1,001 - $15,000 | Est. $8,000 (midpoint of reported range $1,001–$15,000) | Self | Merrill Lynch Investment Account #025 | Jan 13, 2026 | 260 days Late | PTR ↗ |
| Ritchie Torres Politician | Sep 26, 2024 | ABBV | AbbVie Inc. Common Stock (ABBV) [ST] | Purchase | $1,001 - $15,000 | Est. $8,000 (midpoint of reported range $1,001–$15,000) | Self | — | Aug 20, 2025 | 328 days Late | PTR ↗ |
| Lisa McClain Politician | Jun 17, 2025 | ABBV | AbbVie Inc. Common Stock (ABBV) [ST] | Purchase | $1,001 - $15,000 | Est. $8,000 (midpoint of reported range $1,001–$15,000) | Spouse | Charles Schwab Brokerage Account 924 | Aug 13, 2025 | 57 days Late | PTR ↗ |
| John James Politician | Nov 10, 2023 | ABBV | AbbVie Inc. Common Stock (ABBV) [ST] | Purchase | $1,001 - $15,000 | Est. $8,000 (midpoint of reported range $1,001–$15,000) | Self | John A. James Children’s Trust | Sep 2, 2024 | 297 days Late | PTR ↗ |